Public health is one of the major societal challenges of France. The healthcare sector is strategic and prompting France to be competitive.
Cellectis is the world’s largest biotechnology firm designing, manufacturing and engineering human cells and cell lines for drug discovery and development. To understand its business model, it is important to grasp the implications of groundbreaking research on Induced Pluripotent Stem (IPS), conducted by Professor Shinya Yamanaka, winner of the Nobel Prize for Medicine.
Copyright © 2015 Business France - All rights reserved